Our Technology

A New Era in Regenerative Therapeutics

We have developed a proprietary platform that harnesses the power of induced pluripotent stem cells (iPSCs) to generate tissue specific exosomes, unlocking a new frontier in targeted therapeutics.

By combining the flexibility of iPSC technology with the therapeutic precision of exosomes, we have created a scalable high-impact platform capable of addressing complex diseases.

• Proprietary Differentiation Protocols - Tailored iPSC differentiation methods enable exosome production from specific tissue types relevant to targeted diseases.

• Scalable & Consistent Manufacturing - Robust, reproducible process optimized for clinical-grade scalability and batch-to-batch consistency.

• High Target Specificity - Exosomes carry cell type specific cargo, enhancing therapeutic precision and potentially minimizing off- target effects.

• Effective and scalable regenerative therapies - Combining iPSC technology with exosome-based therapies creates a powerful new approach to regenerative medicine.